Mostrando 10 resultados de: 43
Filtros aplicados
Publisher
American Journal of Therapeutics(14)
Revista Latinoamericana de Hipertension(11)
Vessel Plus(4)
Archivos Venezolanos de Farmacologia y Terapeutica(3)
Current Pharmaceutical Design(3)
Área temáticas
Fisiología humana(22)
Farmacología y terapéutica(15)
Salud y seguridad personal(6)
Medicina y salud(5)
Problemas sociales y servicios a grupos(4)
Área de conocimiento
Enfermedad cardiovascular(15)
Medicina interna(15)
Fisiología(8)
Diabetes(6)
Farmacología(5)
AMPK as target for intervention in childhood and adolescent obesity
ReviewAbstract: Childhood obesity is a major worldwide health problem. Intervention programs to ameliorate the ratePalabras claves:Autores:Aguirre M.A., Arráiz N., Rojas-Quintero J., Valmore Bermúdez, Velasco M.Fuentes:scopusCigarette smoking and cardiovascular disease
ReviewAbstract: Cigarette smoking is considered a risk factor for many diseases especially for cardiovascular diseasPalabras claves:Cardiovascular disease, risk factor, smokingAutores:Aguirre M.A., Aparicio D., Bustamante M., Canelón R., Finol F., Luis Xavier Enríquez Acosta, Urdaneta A., Valmore Bermúdez, Velasco M.Fuentes:scopusAssociation between apoliprotein E gene polymorphism and hypercholesterolemic phenotype in maracaibo, Zulia State, Venezuela
ArticleAbstract: Apoliprotein (Apo) E gene polymorphisms have been associated with high plasma lipids levels and cardPalabras claves:ApoE, Cardiovascular disease, hypercholesterolemia, Lipids profile, polymorphismsAutores:Arráiz N., Carem Prieto, Escalona C., Reyes F., Rondón N., Sánchez M.P., Sanz E., Valmore Bermúdez, Velasco M.Fuentes:scopusBiologic Behavior and optimal cut-off point estimation for Serum Fasting Insulin: A report from the Maracaibo City Metabolic Syndrome Prevalence Study
ArticleAbstract: Introduction: Insulin resistance is a metabolic state in which tissue effects of insulin are diminisPalabras claves:Cut-off point, hyperinsulinemia, Insulin, Insulin Resistance, Metabolic syndromeAutores:Amell A., Arráiz N., Calvo M.J., Carem Prieto, Chávez C., Chávez-Castillo M., David A., Escalona C., Gómez M.C., Lubo A., Martínez M.S., Mengual-Moreno E., Rojas-Quintero J., Romero J., Salazar-Vílchez J., Toledo A., Valero P., Valmore Bermúdez, Velasco M.Fuentes:googlescopusAnti-aging effect of metformin: A molecular and therapeutical perspective
ReviewAbstract: Aging is a time-dependent inevitable process, in which cellular homeostasis is affected, which has aPalabras claves:ageing, Anti-ageing drugs, Geronto-protective properties, Metformin, Type 2 Diabetes mellitusAutores:Cano-Ponce C., D’marco L., Galbán N., Gomez Y., González M.C., Herazo Y., Morillo V., Nava M., Rojas M., Rojas-Quintero J., Torres W., Valmore Bermúdez, Velasco M.Fuentes:scopusApproach to a successful selection of antihypertensive drugs for the patient with atherosclerosis
ArticleAbstract: Coronary heart disease has become a medical and public health issue associated with multiple risk faPalabras claves:ACE inhibitors, atherosclerosis, Coronary heart disease, Hypertension, myocardial infarctionAutores:Rojas E.R., Valmore Bermúdez, Velasco M.Fuentes:scopusEffect of drugs interacting with the dopaminergic receptors on glucose levels and insulin release in healthy and type 2 diabetic subjects
ArticleAbstract: Dopamine agonists play an important role in the regulation of the central nervous-cardiovascular, rePalabras claves:dopamine, Dopaminergic agonists, Dopaminergic receptors, Hypertension, Insulin, Type 2 Diabetes mellitusAutores:Bolívar H., Cano R.A., Contreras F., Foullioux C., Lares M., Leal E.M., Maroun C., Pacheco B., Valmore Bermúdez, Velasco M.Fuentes:scopusDetermination of Non-HDL cholesterol in diabetic and hypertensive patients
ArticleAbstract: Recently, it has been suggested that non-high-density lipoprotein (non-HDL) cholesterol measure is aPalabras claves:atherosclerosis, LDL, Non-HDL cholesterolAutores:Castro J., Contreras F., Dowling V., González M.C., Guerra-Torres X.E., Lares M., Rojas-Quintero J., Valmore Bermúdez, Velasco M.Fuentes:scopusEffects of metoclopramide and metoclopramide/dopamine on blood pressure and insulin release in normotensive, hypertensive, and type 2 diabetic subjects
ArticleAbstract: The objective is to determine cardiovascular and insulin release effects under metoclopramide (MTC)Palabras claves:dopamine, Dopamine receptors, Hypertension, Insulin release, Metoclopramide, Type 2 DiabetesAutores:Bolívar H., Cano R.A., Contreras F., Fouillioux C., González M.C., Hernández-Hernandez R., Lares M., Valmore Bermúdez, Velasco M.Fuentes:scopusHaemodynamical variables versus endothelial hormones in hypertensive and type 2 diabetic patients with endothelial dysfunction
ArticleAbstract: Leptin is a 167 aminoacid peptidic hormone secreted by adipose tissue. It works mainly in the hypothPalabras claves:C reactive protein, Hypertension, leptin, Nitric oxide, Type 2 Diabetes mellitusAutores:Cano R.A., Contreras F., Fouillioux C., González M.C., Gotera D., Lares M., Magaldi L., Mayda C.L., Pacheco B., Rojas-Quintero J., Valmore Bermúdez, Velasco M.Fuentes:scopus